CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effects of POL6326 (CXCR4 antagonist) as a
stem cell mobilizing agent, on cardiac function and infarct size and on safety and
tolerability, in patients with reperfused ST-Elevation Myocardial Infarction (STEMI).